Balancing science and public policy in Pakistan's COVID-19 response.
East Mediterr Health J
; 27(8): 798-805, 2021 Aug 26.
Article
in English
| MEDLINE | ID: covidwho-1395698
ABSTRACT
BACKGROUND:
Coronavirus disease 2019 (COVID-19) has affected the world in an unprecedented manner and South Asian countries were among the first to experience imported cases. Pakistan's response to COVID-19 has been under scrutiny for its granularity, reach and impact.AIMS:
to evaluate objectively the chronology and depth of the response to COVID-19 in Pakistan.METHODS:
We evaluated available national and subnational epidemiological and burden information on COVID-19 cases and deaths in Pakistan, including projection models available to the Government at an early stage of the pandemic.RESULTS:
Pakistan, with a population of 215 million and considerable geographic diversity, experienced case introduction from pilgrims returning from the Islamic Republic of Iran, followed by widespread community transmission. The National Command and Operations Centre, established through civilian and military partnership, was critical in fast tracking logistics, information gathering, real-time reporting and smart lockdowns, coupled with a massive cash support programme targeting the poorest sections of society. Cases peaked in June 2020 but the health system was able to cope with the excess workload. Since then, although testing rates remain low (> 300 000 cases confirmed to date), case fatality rates have stabilized, and with 6300 deaths, Pakistan seems to have flattened the COVID-19 curve.CONCLUSION:
Despite notable successes in controlling the pandemic, several weaknesses remain and there are risks of rebound as the economy and educational systems reopen. There is continued need for strong technical and programmatic oversight, linked to civic society engagement and working with religious scholars to ensure nonpharmacological intervention compliance.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Public Policy
/
Communicable Disease Control
/
COVID-19
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
East Mediterr Health J
Journal subject:
Medicine
Year:
2021
Document Type:
Article
Affiliation country:
Emhj.21.016
Similar
MEDLINE
...
LILACS
LIS